drug · small molecule
VIVITROL
updated 3mo ago/ /ˌnælˈtrɛksoʊn/ /
by $ALKS Alkermes plc.🔗 ChEMBL
community read0 votes
🐶 often sniffed alongside
top 4Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 47 investigational indications.
targets
Opioid receptors; mu/kappa/delta
all catalysts(0)
nothing on the calendar yet
Trials studying VIVITROL
- phase4A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial)
- phase4Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
- phase3Combination Gerotherapeutic Interventions for Healthspan Improvement
- phase3Evaluate the Efficacy and Safety of Naltrexone Hydrochloride Implant in Patients With Alcohol Use Disorder
- phase2Evaluation of the O'Neil Long Acting Naltrexone Implant in Opioid Dependent Persons
- phase1iSTEP-N 101b: Pharmacokinetics and Safety Study of Low- and High-Dose Naltrexone Implants vs Monthly Vivitrol in Healthy Volunteers
- phase4A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America
- phase2Phase II Clinical Study on the Efficacy and Safety of Naltrexone Implant in Patients With Alcohol Use Disorder
News(4)
- 4 potential biotech M&A targets, plus a pretty sure bet from J&JPharma is definitely interested in making more deals. But what biotechs will come under the magnifying glass? BioSpace takes a look at companies that analysts see as near-term targets for buyouts.biospace · 6d ago
- 12 ideas for tackling the U.S. alcohol epidemicThe U.S. can save lives from excess alcohol use without taking drastic measures. Here are 12 steps that can help.stat · 28d ago
- Alkermes’ incoming CEO has a plan to outplay Lilly and TakedaBlair Jackson says the next 12 months may be the most important in Alkermes’ history, as the brain drugmaker races to join an “orexin” market that analysts see as a multibillion-dollar opportunity.biopharma_dive · 1mo ago
- Are Republicans turning against medications for treating opioid addiction?Federal actions and proposals have reignited debate over methadone and buprenorphine, worrying addiction experts and patient groups.stat · 2mo ago
Data sources
last refreshed 29m ago
Found something off?
comments(0)
5-min edit window · permanent after that